I want to ask if anyone knows any information about Niraparib (Zejula)? From what I currently know it's a maintenance drug for ovarian cancer by Tesaro Drugs.
There is a campaign called: Not on My Watch
"about the importance of maintenance therapy.." I just saw it posted on my facebook. Wondering if this is or will be approved in Canada and what patient population with ovarian cancer are eligible for it? For ex. is it just for the brca gene or any ovarian cancer patients?
The last time I read about Zejula was last year and it was just the US at the time. Trying to understand this and other maintenance therapies more, for women who do not fall into the "brca gene" group as I have recently learned that only they have access to Olaparib parp inhibitors.
Would like to see more options for other ovarian cancer types as well.
Thank you in advance